119 related articles for article (PubMed ID: 29954492)
1. Cytotoxicity of Graphene Oxide (GO) and Graphene Oxide Conjugated Losartan Potassium (GO-LP) on Neuroblastoma (NB41A3) Cells.
Kaur R; Verma S; Joshi P; Singh SP; Singh M
J Nanosci Nanotechnol; 2018 Oct; 18(10):6765-6775. PubMed ID: 29954492
[TBL] [Abstract][Full Text] [Related]
2. Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.
Yuan YG; Wang YH; Xing HH; Gurunathan S
Int J Nanomedicine; 2017; 12():5819-5839. PubMed ID: 28860751
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of hesperetin-loaded graphene oxide nanosheets (Hsp-GO) as a drug delivery system for colon cancer: synthesis and anticancer efficiency assessment.
Hadi AS; Haghi M; Barzegar A; Ali M; Feizi H
Mol Biol Rep; 2024 Apr; 51(1):591. PubMed ID: 38683228
[TBL] [Abstract][Full Text] [Related]
4. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
5. GO Nanosheets: Promising Nano Carrier for the S29, 1-(2-Chloro-2-(4-chlorophenyl-ethyl)-
Mardente S; Aventaggiato M; Mari E; Francioso A; Tafani M; Mosca L; Zicari A; Malyshev I; Kuznetsova L; Valentini F
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899395
[TBL] [Abstract][Full Text] [Related]
6. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
[TBL] [Abstract][Full Text] [Related]
7. Natural and synthetic polymer for graphene oxide mediated anticancer drug delivery-A comparative study.
Deb A; R V
Int J Biol Macromol; 2018 Feb; 107(Pt B):2320-2333. PubMed ID: 29055699
[TBL] [Abstract][Full Text] [Related]
8. Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy.
Verde V; Longo A; Cucci LM; Sanfilippo V; Magrì A; Satriano C; Anfuso CD; Lupo G; La Mendola D
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759830
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.
Imani R; Emami SH; Faghihi S
Phys Chem Chem Phys; 2015 Mar; 17(9):6328-39. PubMed ID: 25650242
[TBL] [Abstract][Full Text] [Related]
10. Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO
Zhu R; Wang Z; Liang P; He X; Zhuang X; Huang R; Wang M; Wang Q; Qian Y; Wang S
Acta Biomater; 2017 Nov; 63():163-180. PubMed ID: 28923539
[TBL] [Abstract][Full Text] [Related]
11. Graphene Oxide-Silver Nanoparticles Nanocomposite Stimulates Differentiation in Human Neuroblastoma Cancer Cells (SH-SY5Y).
Gurunathan S; Kim JH
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29182571
[TBL] [Abstract][Full Text] [Related]
12. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
13. Stable Dispersions of Covalently Tethered Polymer Improved Graphene Oxide Nanoconjugates as an Effective Vector for siRNA Delivery.
Yadav N; Kumar N; Prasad P; Shirbhate S; Sehrawat S; Lochab B
ACS Appl Mater Interfaces; 2018 May; 10(17):14577-14593. PubMed ID: 29634909
[TBL] [Abstract][Full Text] [Related]
14. Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.
Gurunathan S; Han JW; Kim ES; Park JH; Kim JH
Int J Nanomedicine; 2015; 10():2951-69. PubMed ID: 25931821
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity of GO-DOx on FaDu squamous carcinoma cell lines.
Singh M; Gupta P; Baronia R; Singh P; Karuppiah S; Shankar R; Dwivedi PD; Singh SP
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):107-111. PubMed ID: 29593407
[TBL] [Abstract][Full Text] [Related]
16. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
Zheng XT; Ma XQ; Li CM
J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
19. Biophysical binding profile with ct-DNA and cytotoxic studies of a modulated nanoconjugate of umbelliferone cobalt oxide loaded on graphene oxide (GO) as drug carrier.
Yousuf S; Arjmand F; Siddique HR; Ali MS; Al-Lohedan HA; Tabassum S
J Biomol Struct Dyn; 2022 Jul; 40(10):4558-4569. PubMed ID: 33331234
[TBL] [Abstract][Full Text] [Related]
20. Graphene oxide - gelatin nanohybrids as functional tools for enhanced Carboplatin activity in neuroblastoma cells.
Makharza S; Vittorio O; Cirillo G; Oswald S; Hinde E; Kavallaris M; Büchner B; Mertig M; Hampel S
Pharm Res; 2015 Jun; 32(6):2132-43. PubMed ID: 25537340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
